Similarly, CD19+ cells demonstrated significantly decreased TRPM3 expression in CFS/ME (1.56 ± SEM 0.191 %) compared with healthy controls (2.06 ± SEM 0.16 %) (Fig. 2b). The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.